1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
| Product Code | Kato III; Kato-III; KATO-III; KATOIII; KatoIII; KATO 3 |
| Species | Human |
| Cat.No | ABC-TC0493 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Stomach |
| Disease | Gastric Cancer |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Gastric Cancer Cell Lines |
KATO III is a human gastric carcinoma cell line that was originally isolated from the pleural effusion of a 55-year-old, Asian male patient with stomach cancer. KATO III exhibits spherical morphology and semi-adherent culture properties. This cell line is tumorigenic but does not form tumors in nude mice. Notably, KATO III cells are negative for p53 expression and positive for carcinoembryonic antigen (CEA) expression.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
KATO III is a human gastric carcinoma cell line extensively used in cancer research. It supports the screening of compounds that induce apoptosis or exhibit cytotoxicity in gastric cancer cells. Additionally, it is employed to identify drug candidates for treating digestive tract cancers, especially in overcoming chemotherapy resistance. This cell line is instrumental in advancing therapeutic strategies for gastric malignancies.
